Two experiments were conducted in which cimateroI [CL263,780; 5-[1-hydroxy-2-(isopropylamino) ethyl]-)] was fed at 0 or 10 ppm in a complete, mixed, high-concentrate diet to assess effects on growth performance and repartitioning of tissue growth in young, rapidly growing lambs. Average daily gain and feed efficiency (F/G) were not altered in Dorset wether lambs fed cimaterol for 6 or 11 wk in Exp. 1. Average daily gain and F/G were improved 16% (P<.05) in Suffolk X Dorset ram lambs fed cimaterol for 5 wk, but not 10 wk in Exp. 2. Cimaterol increased dressing percent by at least 3 percentage units (P<.05), increased longissimus area 26 and 32% (P<.001), reduced 12th-rib fat thickness 66 and 32% (P<.001) and reduced kidney and pelvic fat 34 and 44% (P<.001) at 6 wk and 12 wk, respectively (Exp. 1). Proximal hindleg muscles were 26% heavier (P<.001) in cimaterol-fed lambs in Exp. 1. Fishmeal (FM) replaced an equal amount of soy protein (3% of diet) to create a 2 • 2 • 2 factorial arrangement in Exp. 2. Cimaterol effects on carcass traits and muscle growth were similar to those observed in Exp. 1. However, hindleg and foreleg muscle weights and longissmus area were 16% greater (P<.001) in FM-fed lambs at 10 wk, and the cimaterol-induced muscle hypertrophy was slightly reduced in these lambs. Fat measures were unaffected by FM. These data demonstrate that cimaterol effectively repartitions skeletal muscle and adipose tissue accretion, and fishmeal fed for 10 wk significantly enhances skeletal muscle growth in lambs.
Introduction
Production efficiency of meat animals can be defined as the return of saleable product per unit of feed input, but composition of the product is also an important factor in determining the per unit value of the product and the cost of producing it. Reducing the rate of adipose tissue accretion and increasing the rate of skeletal muscle growth should improve the efficiency of growth unless the maintenance requirement is also increased to offset this effect.
Dietary administration of the beta-adrenergic agonist clenbuterol markedly improves carcass composition and feed conversion in finishing wether lambs and broiler chickens (Dalrymple et al., 1984b) , and markedly improves carcass traits of finishing steers . Another adrenomimeric compound, cimaterol, improves carcass traits and composition in finishing swine (Dalrymple et al., 1984a; Moser et al., 1984) . Effects of cimaterol on growth performance or tissue growth patterns in growing-finishing lambs have not been reported.
Plane of nutrition can affect efficiency of growth in lambs, but has little or no affect on body composition when comparisons are made on a constant-weight basis (Reid et al., 1968; Firth, 1984) . Protein gain per unit of weight gain is greater in young growing lambs than in finishing lambs, and ram lambs generally grow faster and more efficiently and have higher carcass cutability and lower dressing percentage 370 J. Anim. Sci. 1986 .62:370-380 than ewe or wether lambs (Deweese et al., 1969; Kemp et al., 1970; Jacobs et al., 1972; Shelton and Carpenter, 1972; Kemp et al., 1976; Makarechian et al., 1978; Lloyd et al., 1981; Lirette et al., 1984) . Feed efficiency in young, rapidly growing lambs is significantly improved when fishmeal is added to the diet at a level of 2 to 8% to replace a portion of the major protein source, soybean meal (Adam, 1982; Adam et al., 1982) . The authors suggest that this response is related to reduced rumen solubility of fishmeal and greater amino acid availability for growth.
In view of these findings, we conducted two experiments. The first was conducted to determine the effects of short-vs long-term administration of the synthetic beta-agonist cimaterol on growth performance, carcass characteristics and skeletal muscle growth in young, rapidly growing wether lambs. The second experiment was designed to evaluate the effects of cimaterol and fishmeal replacement of a portion of the soybean meal in the diet on the same variables in crossbred ram lambs.
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Materials and Methods
Cimaterol [CL263,780; (anthranilonitrile, 5-[1-hydroxy-2-(isopropylamino) ethyl]-)], was administered at 10 ppm in a total, mixed, highconcentrate diet fed ad libitum for short (5 or 7 wk) or prolonged (10 or 12 wk) periods. The 10 ppm dose level was chosen to achieve a maximal response, based on data from earlier studies with clenbuterol. American Cyanamid Company 4 provided the premix containing the cimaterol used in these studies. The experiments were conducted at the Cornell University Teaching and Research Sheep Unit.
Exp. I. Twenty-four early-weaned (6 to 8 wk) Dorset wether lambs were randomly assigned to 12 raised, expanded metal pens and to treatment groups. Lambs were chosen by weight for closeness to the desired initial average body weight, 17 kg. Lambs were fed a total, mixed high-concentrate diet (table 1), with or without cimaterol, for 7 or 12 wk.
The lambs were subjected to the existing day length photoperiod and ambient temperature environment inside a large, well-ventilated building. The first experiment was begun in March. Feed intake was monitored daily and body weight measured at the beginning and end of each treatment period to obtain growth per-formance data, Feed was withdrawn overnight, and the lambs were shorn before being transported to the Morrison Hall abattoir for slaughter. Body weight was determined before slaughter; the lambs were killed by electrical stunning and exsanguination.
Hot carcass weight was measured before chilling carcasses at 0 to 4 C. Standard carcass measurements, USDA yield grade and quality grade, weights of biceps femoris, semimembranosus and semitendinosus muscles, and wholesale cut weights were determined 24 hr post-slaughter, Exp. 2. Thirty-two young, rapidly growing Suffolk-Dorset crossbred ram lambs, all from the same sire, were randomly assigned to 16 raised pens and four treatment groups in Exp. 2. A 2 • 2 x 2 factorial arrangement was used in this experiment to assess the effects of cimaterol treatment, treatment interval (5 vs 10 wk) and protein source in the diet (soybean meal vs soybean meal plus fishmeal). Shorter treatment periods were used in Exp. 2 to achieve normal slaughter weights at termination of the study. Diets used in Exp. 2 are described in table 1. Lambs weighed an average of 27.8 kg at the beginning of the experiment (May) and were housed in the same facility used in Exp. 1. Growth performance and carcass data were obtained as described for Exp. 1. Additional measurements included weights of infraspinatus, supraspinatus and triceps brachii muscles and carcass length.
The data in Exp. 1 were analyzed by the General Linear Models procedure of the Statistical Analysis System (SAS, 1983) for a threeway classification, fixed main effects model of unbalanced design. Data in Exp. 2 were analyzed by analysis of variance.
Results and Discussion
Growth Performance. Neither average daily gain (ADG) nor feed to gain ratios (F/G) were significantly affected by cimaterol treatment in Exp. 1 (table 2). Average daily gain was significantly increased and F/G were significantly reduced by cimaterol administration during the 5-wk treatment period in Exp. 2 (table 3) . These data are in agreement with those of Baker et al. (1984) , who observed increased rate of gain and decreased F/G with 8 wk administration of clenbuterol. Lambs used in our experiments exhibited significantly greater ADG and lower F/G than those observed in the clenbuterol studies, and part of this difference is readily explained by differences in age and breed of lambs used. Replacement of a portion of the soybean meal in the diet by fishmeal significantly improved ADG from 0 to 10 wk in Exp. 2 (table 3) .
Carcass Characteristics. Cimaterol dramatically improved carcass muscle deposition and concomitantly reduced carcass fat in both experiments (figures 1 and 2). All carcass characteristics except hot carcass weight were significantly improved with short-term and long-term administration in both experiments (tables 4 and 5). Addition of fishmeal to the diet (Exp. 2) significantly improved hot carcass weight, dressing percentage, longissimus muscle area and leg conformation ( Longissimus cross-sectional area was increased approximately 30% on the average with cimaterol in both experiments, and fishmeal significantly increased longissimus area by 12% in Exp. 2. Leg conformation score, a visual appraisal of the relative degree of muscling in the leg, also was significantly increased by both cimaterol and fishmeal. The leg conformation scale was found to be inadequate to express the superior muscle development observed in cimaterol-treated lambs (figure 1). The highest scores recorded were consistently found to be those for cimaterol-treated lambs with fishmeal in the diet; however, the effects of cimaterol were reduced when fishmeal was present. These results explain the significant treatment • protein source interaction observed in Exp. 2.
Fat thickness measurements over the center of the longissimus muscle were approximately 50% less in cimaterol-treated lambs in the first experiment (table 4) and approximately 65% less in all but the 10-wk fishmeal group in Exp. 2 (table 5) . In this group, a significant treatment • protein source interaction was observed, which was explained by a lack of significant fat thickness reduction with a long-term administration of cimaterol when fishmeal was present in the diet. When two additional fat thickness measurements over the rib were included in the mean, differences were similar in magnitude and direction in Exp. 1, but were smaller in Exp. 2.
Percent kidney and pelvic fat, determined by weighing rather than visual estimation, was significantly reduced by cimaterol and was unaffected by fishmeal. The range of percent kidney and pelvic fat reduction was 18 to 44%, with a mean reduction of 30%. A significant increase in this fat depot was observed between the 7-and 12-wk sampling times in Exp. 1, as expected, but differences between the 5-wk and 10-wk sampling times were nonsignificant in Exp. 2. This may be explained in part by the differences in mature size between purebred Dorset and Suffolk-Dorset crossbreds, or by the fact that wethers were used in Exp. 1, while rams were used in Exp. 2. USDA quality grade, which is determined by maturity, conformation and fat streaking in the flank, was not influenced by cimaterol administration or fishmeal, and did improve with time.
USDA yield grade was significantly improved by cimaterol administration in both experiments (tables 4 and 5), and was influenced by time as well. Administration of cimaterol reduced yield grade by one whole unit in Exp. 1, and by one-half unit or more in all but the 10-wk fishmeal group in Exp. 2. The significant treatment x protein source interaction for yield bcimaterol added as a premix at 10 ppm.
CRepresents preslaughter shorn and overnight-fasted weights. dprime+ = 13, Prime avg. = 12, Prime-= 11, Choice+ = 10, Choice avg. = 9, Choice-= 8.
e'f'g'hMeans within a row that do not have a common superscript differ (P<.05).
grade was explained by a reduced effect of cimaterol when fishmeal was present. Carcass length was significantly less in cimateroI-treated lambs (table 5) and was unaffected by fishmeal.
Wholesale Cut Weigbts. Both the wholesale leg and rack were significantly increased in size (10 to 15%) in response to cimaterol (table 6) . Fishmeal significantly improved weights of leg, rack and shoulder by 8 to 10%. An indication that distribution of wholesale cuts was changed with cimaterol was found when wholesale cuts were compared on a percentage of hot carcass weight basis. The leg represented a higher percentage of carcass weight in both experiments, and the rack constituted a greater part of the carcass in Exp. 1 (P<.05).
Individual Muscle Weights. The hindleg muscles, biceps femoris, semimembranosus and semitendinosus, were 25 to 30% larger in lambs fed cimaterol (tables 6 and 7). Fishmeal also caused a significant increase in weights of these muscles, but to a lesser extent (table 7) . The degree of muscle hypertrophy achieved with fishmeal in Exp. 2 was approximately 4.5% after 5 wk, but was over 16% at 10 wk. Although no significant treatment x protein interactions were found, the percentage of muscle enlargement with cimaterol was always greater in the soybean-meal-fed lambs than in those receiving fishmeal as well. These differences were greater in the foreleg muscles than the hindleg muscles, where the magnitude of the fishmeal response was similar to that observed in three hindleg muscles (9 to 11%). Although the triceps brachii was always larger in cimaterol-fed lambs, the supraspinatus was not significantly affected by cimaterol, and the response of the infraspinatus was not consistent across time-protein source subgroups.
Discussion
Results from these studies demonstrate that cimaterol is capable of repartitioning tissue ET AL. growth in lambs to improve markedly carcass characteristics and composition. Short-term and long-term administration were equally effective in enhancing skeletal muscle growth and reducing fat accretion in wether and ram lambs. These changes were achieved without significantly altering growth rate, feed intake or feed efficiency. Although marked improvement in feed efficiency would be expected with the dual reciprocal response observed, increased basal metabolic rate may have increased the maintenance requirement sufficiently to offset the efficiency gained by altering muscle and fat accretion. We have observed acute elevation of heart rate, mean arterial blood flow and plasma thyroid hormone concentrations in lambs fed cimaterol (D. H. Beermann, unpublished data). Heart rate and body temperature are both increased significantly with acute infusion of clenbuterol in lambs (P. J. Reeds, personal communication). Significant increases in glucose oxidation to CO2 and glucose incorporation into glycogen have been observed in vitro with skeletal muscle strips from lambs given clenbuterol (S. B. Smith, personal communication). Cimaterol-fed lambs exhibited significantly higher postmortem ultimate muscle pH, indicating less muscle glycogen present at slaughter (D. H. Beermann, unpublished data).
Changes in both carbohydrate and lipid metabolism in cimaterol-fed lambs may be mediated through elevated cyclic-AMP levels.
Epinephrine, a beta~-agonist, stimulates glycogen phosphorylase activity, inhibits glycogen synthase and stimulates lipolysis via elevated cyclic-AMP (Fain and Garcia-Sainz, 1983) . Plasma concentration of nonesterified fatty acids (NEFA) was significantly higher and muscle lipid content significantly lower in wether Iambs fed 10 ppm cimaterol in Exp. 1. Taken together, results from these and other studies suggest that cimaterol stimulates lipolysis and use of NEFA as an energy substrate in lambs. This would allow for amino acids otherwise destined for use in gluconeogenesis, an ongoing process in ruminants, to be spared and made available to support greater rates of protein accretion.
The cimaterol-induced muscle hypertrophy observed in both studies may result from greater rates of protein synthesis; however, reduced protein degradation may also be a contributing factor. Emery et al. (1984) showed that the fractional rate of protein synthesis is increased 34 or 26% in rats administered the beta-agonists clenbuterol and fenoterol, respectively. Epinephrine and other beta-agonists reduce muscle protein catabolism (Hill and Malamud, 1974; Li and Jefferson, 1977; Tischler, 1981) .
The enhancement of muscle growth observed with fishmeal addition to the diet to replace an equal amount of soy protein has not been previously reported. Fishmeal, used at 3% of the diet in Exp. 2, significantly improved all carcass measures of skeletal muscle development and significantly increased the weight of differerit muscles to a similar degree. Long-term (10 wk) fishmeal feeding produced threefold greater muscle hypertrophy than short-term (5 wk) feeding. This may be related to greater rumen capacity and greater rumen degradation of soy protein in older lambs. We suggest that fishmeal provides greater rumen escape of protein and greater availability and absorption of amino acids to facilitate enhanced muscle growth.
The effects of cimaterol and fishmeal were not strictly additive. Cimaterol appeared only one-half as effective in enhancing the size of the three foreleg muscles in lambs fed fishmeal and soybean meal compared with those receiving only soybean meal. This differential effect of cimaterol was not as pronounced in hindleg muscles, and may be related to growth patterns of the muscles. Infraspinatus, supraspinatus and triceps brachii muscles have lower growth coefficients (.86 to .88 as determined by the allometric growth equation Y = ax b) than those for the hindleg muscles (.99 to 1.03; Firth et al., 1982; Lohse et al., 1971) . The foreleg muscles would have achieved a greater percentage of mature size before treatment than hindleg muscles and, therefore, may have retained less potential for growth enhancement. Further studies must be conducted to determine direct effects of cimaterol and fishmeal on muscle protein synthesis and degradation.
